LEASE AGREEMENT BETWEEN RP GATEWAY, LLC, A GEORGIA LIMITED LIABILITY COMPANY AND SYNAGEVA BIOPHARMA CORP., A DELAWARE CORPORATION AND FOLLOWING EXHIBITS EXHIBIT “A” – LEGAL DESCRIPTION & SITE PLAN EXHIBIT “B” – LANDLORD’S WORK & SPECIFICATIONS EXHIBIT...Lease Agreement • March 4th, 2014 • Synageva Biopharma Corp • Biological products, (no disgnostic substances) • Georgia
THIS LEASE, made this 22nd day of October, 2013 (the “Effective Date”), by and between RP GATEWAY, LLC, a Georgia limited liability company, first party (hereinafter called “Landlord”); and SYNAGEVA BIOPHARMA CORP., a Delaware corporation, second party (hereinafter called “Tenant”):
SECOND AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • March 4th, 2014 • Synageva Biopharma Corp • Biological products, (no disgnostic substances) • Georgia
THIS SECOND AMENDED AND RESTATED LICENSE AGREEMENT is made and entered into as of December 3, 2013 (the “Second Restatement Effective Date”), by and between the UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC., a nonprofit Georgia corporation with offices in the Boyd Graduate Studies Research Center, The University of Georgia, Athens, Georgia 30602 (“UGARF”) and SYNAGEVA BIOPHARMA CORP., a Delaware corporation having offices at 33 Hayden Avenue, Lexington, MA 02421 (“Synageva BioPharma”).
